Skip to main content
Top
Published in: Immunologic Research 1/2018

01-02-2018 | Original Article

Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca2+ overload in H295R cells

Authors: Jinghui Lei, Suli Zhang, Pengli Wang, Yang Liao, Jingwei Bian, Xiaochen Yin, Ye Wu, Lina Bai, Feng Wang, Xiaoli Yang, Huirong Liu

Published in: Immunologic Research | Issue 1/2018

Login to get access

Abstract

Preeclamptic women are reported to have inadequate plasma volume expansion coupled with a suppressed secretion of aldosterone; however, the specific mechanism of preeclampsia remains unclear. We demonstrated that the presence of long-term angiotensin II type 1 receptor autoantibody (AT1-AA) reduces aldosterone production by triggering a Ca2+ overload in H295R cells. AT1-AA was discovered in preeclamptic women and reported to activate AT1R, and consequently elevate intracellular Ca2+. We found that AT1-AA significantly prolonged the time of intracellular Ca2+ elevation. Besides promoting aldosterone production as a second messenger, Ca2+ overload shows a cytotoxic effect. Our data reveals that long-term presence of AT1-AA triggered a Ca2+ overload and consequent impairment of aldosterone production, which could be prevented by a PKC inhibitor, Gö 6983, or a calcium channel inhibitor, nifedipine. These findings have clinical significance because AT1R blockers are not recommended for treatment of preeclampsia due to their potential harm to the fetus. Our findings also emphasize a potential clinical benefit of immunoadsorption or neutralization of AT1-AA in preeclamptic women.
Appendix
Available only for authorised users
Literature
3.
go back to reference Gallery ED, Hunyor SN, Gyory AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med. 1979;48(192):593–602.PubMed Gallery ED, Hunyor SN, Gyory AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med. 1979;48(192):593–602.PubMed
12.
go back to reference de Groot CJ, Taylor RN. New insights into the etiology of pre-eclampsia. Ann Med. 1993;25(3):243–9.CrossRefPubMed de Groot CJ, Taylor RN. New insights into the etiology of pre-eclampsia. Ann Med. 1993;25(3):243–9.CrossRefPubMed
13.
go back to reference Bussen SS, Sutterlin MW, Steck T. Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome. Acta Obstet Gynecol Scand. 1998;77(6):609–13.CrossRefPubMed Bussen SS, Sutterlin MW, Steck T. Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome. Acta Obstet Gynecol Scand. 1998;77(6):609–13.CrossRefPubMed
15.
go back to reference Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, et al. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens. 2008;26:1629–35.CrossRefPubMed Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, et al. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens. 2008;26:1629–35.CrossRefPubMed
16.
go back to reference Abadir PM, Jain A, Powell LJ, Xue QL, Tian J, Hamilton RG, et al. Discovery and validation of agonistic angiotensin receptor autoantibodies as biomarkers of adverse outcomes. Circulation. 2017;135:449–59.CrossRefPubMed Abadir PM, Jain A, Powell LJ, Xue QL, Tian J, Hamilton RG, et al. Discovery and validation of agonistic angiotensin receptor autoantibodies as biomarkers of adverse outcomes. Circulation. 2017;135:449–59.CrossRefPubMed
Metadata
Title
Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca2+ overload in H295R cells
Authors
Jinghui Lei
Suli Zhang
Pengli Wang
Yang Liao
Jingwei Bian
Xiaochen Yin
Ye Wu
Lina Bai
Feng Wang
Xiaoli Yang
Huirong Liu
Publication date
01-02-2018
Publisher
Springer US
Published in
Immunologic Research / Issue 1/2018
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-017-8963-6

Other articles of this Issue 1/2018

Immunologic Research 1/2018 Go to the issue